Table 2 Lesion and procedural characteristics
Abellas et al. 2017 | Azzalini et al. 2016 | Fam et al. 2017 | Goktekin et al. 2015 | Kugler et al. 2017 | Lesiak et al. 2016 | Mitomo et al. 2016 | Ojeda et al. 2015 | Ozel et al. 2016 | Saad et al. 2016 | Vaquerizo et al. 2016 | Wiebe et al. 2015 | Yamac et al. 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LAD (%) | 22.2 | 46.4 | 41.9 | 51.4 | 20 | 57.5 | 46.2 | 48 | 34.1 | 41.6 | – | 43.5 | 34.3 |
LCX (%) | 0 | 19.0 | 12.4 | 24.3 | 6.7 | 7.5 | 12.3 | 24 | 17 | 26.6 | – | 8.7 | 25.7 |
RCA (%) | 77.8 | 34.6 | 44.8 | 32.9 | 73.3 | 35 | 40 | 28 | 48.7 | 31.7 | 46 | 47.8 | 40 |
Moderate/Severe calcifications (%) | 66.7 | 45.8 | 70.5 | 28 | 46.7 | 30 | 32.3 | – | – | 0 | 34 | 65.2 | 22.9 |
J-CTO score ≥ 2 | 55.5 | 42.5 | 100 | – | 60 | 55 | 64.6 | 46 | 29.2 | – | 26 | – | – |
RVD (mm) | 3.39 ± 0.22 | 3.0 ± 0.4 | 2.71 ± 0.55 | – | 3.24 ± 0.46 | 2.48 ± 0.33 | 2.97 ± 0.36 | 3.03 ± 0.4 | 2.8 ± 0.25 | 3.1 ± 0.5 | 2.48 ± 0.48 | – | 3.02 ± 0.39 |
Mean number of BRS implanted | 3.22 | 2.2 ± 1.1 | 2.44 ± 1.12 | 2.01 ± 1.0 | 3.2 ± 1.3 | 1.6 (1–4) | 1.8 ± 0.7 | 2.6 ± 1.9 | 1.27 | 1.63 | – | 2.8 ± 1.0 | 2.3 ± 0.9 |
Mean BRS diameter (mm) | 3.29 ± 0.31 | 3.2 ± 0.4 | 3.00 ± 0.31 | 3.0 ± 0.4 | – | 2.90 ± 0.32 | 3.0 ± 0.4 | 3.030 ± 38 | 2.8 ± 0.29 | 3.1 ± 0.4 | – | 3.1 ± 0.2 | 3.2 ± 0.4 |
Total BRS length (mm) | 21.93 ± 6.45 | 51.3 ± 24.1 | 59.75 ± 25.85 | 36.5 ± 19.5 | 81.7 ± 29.1 | 42.4 ± 21.5 | 47.6 ± 19.9 | 43 ± 21 | 25.6 ± 4.2 | 26 ± 14.7 | 53 ± 23 | 64.8 ± 24.2 | 58.3 ± 23.3 |
Post-dilation (%) | 88.9 | 90.8 | 89.5 | 100 | 100 | 95 | 100 | 100 | 97.5 | 25.7 | 63 | 69.6 | 100 |
Mean post-dilation Balloon diameter (mm) | 3.45 ± 0.28 | 3.3 ± 0.4 | 3.35 ± 0.44 | 3.5 ± 0.4 | 3.3 ± 0.4 | 3.15 ± 0.35 | 3.3 ± 0.3 | – | – | – | – | – | 3.4 ± 0.4 |